Recruited 8,000 volunteers already for phase 3 trials: Bharat Biotech head

The company says they are '200% transparent' about serious adverse events with regulator

Hyderabad based vaccine major Bharat Biotech, which has applied for an accelerated approval from the drug regulator based on phase 1 and 2 clinical trial data last week, said that they have already recruited 8,000 volunteers for a 22,000 subjects phase 3 clinical trial.

Speaking at a FICCI event, Krishna Ella, chairman and managing director of Bharat Biotech International (BBIL) said that they have already recruited 8000 people for its phase 3 clinical trials. "Out of 22,000 volunteers, we have already recruited around 8000 volunteers. In the last fifteen days we have recruited actively," he said.

BBIL began the phase